Related Experiment Video
Updated: Dec 30, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation
Hayley I Muendlein1, Joseph Sarhan2, Beiyun C Liu3
1Graduate Program in Genetics, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.
Abstract:
Receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) are well known for their capacity to drive necroptosis via mixed-lineage kinase-like domain (MLKL). Recently, RIPK1/3 kinase activity has been shown to drive inflammation via activation of MAPK signaling. However, the regulatory mechanisms underlying this kinase-dependent cytokine production remain poorly understood. In the present study, we establish that the kinase activity of RIPK1/3 regulates cytokine translation in mouse and human macrophages. Furthermore, we show that this inflammatory response is downregulated by type I interferon (IFN) signaling, independent of type I IFN-promoted cell death. Specifically, low-level constitutive IFN signaling attenuates RIPK-driven activation of cap-dependent translation initiation pathway components AKT, mTORC1, 4E-BP and eIF4E, while promoting RIPK-dependent cell death. Altogether, these data characterize constitutive IFN signaling as a regulator of RIPK-dependent inflammation and establish cap-dependent translation as a crucial checkpoint in the regulation of cytokine production.
Insights
Receptor-interacting protein kinase 1 and 3 (RIPK1/3) kinase activity drives cytokine production. Constitutive type I interferon (IFN) signaling suppresses this inflammation by inhibiting translation initiation, independent of cell death.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Receptor-interacting protein kinase 1 and 3 (RIPK1/3) are known to induce necroptosis and inflammation via MAPK signaling.
- The precise regulation of RIPK1/3 kinase activity in cytokine production remains unclear.
Purpose of the Study:
- To investigate the role of RIPK1/3 kinase activity in regulating cytokine translation.
- To elucidate the mechanisms by which type I interferon (IFN) signaling modulates RIPK1/3-driven inflammation.
Main Methods:
- Utilized mouse and human macrophages to study cytokine production.
- Investigated the impact of type I IFN signaling on RIPK1/3-mediated inflammatory pathways.
- Analyzed the activation of cap-dependent translation initiation components (AKT, mTORC1, 4E-BP, eIF4E).
Main Results:
- RIPK1/3 kinase activity was found to regulate cytokine translation in macrophages.
- Type I IFN signaling downregulated RIPK1/3-driven inflammation independently of cell death.
- Constitutive IFN signaling inhibited AKT/mTORC1/4E-BP/eIF4E pathway activation, reducing cytokine translation.
- IFN signaling promoted RIPK1-dependent cell death.
Conclusions:
- Constitutive type I IFN signaling acts as a negative regulator of RIPK1-dependent inflammation.
- Cap-dependent translation initiation is a critical regulatory checkpoint for cytokine production.
- These findings provide new insights into the interplay between RIPK1, IFN signaling, and inflammatory responses.
Related Concept Videos
Experimental RNAi
Regulation of the Unfolded Protein Response
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
The JAK-STAT Signaling Pathway
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

